Vimarsana
Biggest News Aggregation in the World

Contained Rage News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Contained Rage. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Contained Rage Today - Breaking & Trending Today

John Green vs. Johnson & Johnson (Part 2) - California Healthline - Vimarsana News

John Green vs. Johnson & Johnson (Part 2) - California Healthline

The high price of lifesaving tuberculosis drugs makes them inaccessible to many who need them most. On this episode of “An Arm and a Leg,” hear how a decades-long global fight to reform drug patents is helping to lower the cost.

John Green vs. Johnson & Johnson (Part 2) - KFF Health News - Vimarsana News

John Green vs. Johnson & Johnson (Part 2) - KFF Health News

The high price of lifesaving tuberculosis drugs makes them inaccessible to many who need them most. On this episode of “An Arm and a Leg,” hear how a decades-long global fight to reform drug patents is helping to lower the cost.

Author John Green takes J&J to task for plans to extend patent on TB drug - Vimarsana News

Author John Green takes J&J to task for plans to extend patent on TB drug

The Greens were not alone in calling for J&J to not enforce its secondary patents on the TB drug as Doctors Without Borders issued a similar request in late April.

After Pushback, J&J Allows Generics of Its TB Drug - Vimarsana News

After Pushback, J&J Allows Generics of Its TB Drug

A Swiss non-profit will be allowed to bring generic bedaquiline to lower-income countries

Johnson & Johnson Letting Nonprofit Distribute Life-Saving Generic Tuberculosis Drug—Greatly Expanding Access In Poorer Countries - Vimarsana News

Johnson & Johnson Letting Nonprofit Distribute Life-Saving Generic Tuberculosis Drug—Greatly Expanding Access In Poorer Countries

The drug manufacturer faced an online pressure campaign championed by novelist John Green before the announcement Thursday, which lets Stop TB Partnership offer cheaper generic versions of Johnson & Johnson’s tuberculosis drug in 44 more countries.

Source: forbes.com